Biohaven Pharma (BHVN) Q2 NURTEC ODT Sales Rise to $93M

Go back to Biohaven Pharma (BHVN) Q2 NURTEC ODT Sales Rise to $93M
(NYSE: BHVN) Delayed: 13.94 +0.32 (2.35%)
Previous Close $13.62    52 Week High
Open $13.90    52 Week Low
Day High $14.49    P/E N/A 
Day Low $13.56    EPS
Volume 1,863,834